Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NNOX Stock Forecast 2025-2026
$5.24
Current Price
$334.11M
Market Cap
Buy 4
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to NNOX Price Targets
+186.3%
To High Target of $15.00
+119.5%
To Median Target of $11.50
+71.8%
To Low Target of $9.00
NNOX Price Momentum
+4.0%
1 Week Change
+13.7%
1 Month Change
-48.0%
1 Year Change
-27.2%
Year-to-Date Change
-52.4%
From 52W High of $11.00
+39.7%
From 52W Low of $3.75
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Nano-X (NNOX) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NNOX and similar high-potential opportunities.
Latest NNOX Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, NNOX has a bullish consensus with a median price target of $11.50 (ranging from $9.00 to $15.00). Currently trading at $5.24, the median forecast implies a 119.5% upside. This outlook is supported by 4 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jason Kolbert at D. Boral Capital, projecting a 186.3% upside. Conversely, the most conservative target is provided by Ross Osborn at Cantor Fitzgerald, suggesting a 71.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NNOX Analyst Ratings
4
Buy
0
Hold
0
Sell
NNOX Price Target Range
Low
$9.00
Average
$11.50
High
$15.00
Current: $5.24
Latest NNOX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NNOX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 17, 2025 | D. Boral Capital | Jason Kolbert | Buy | Maintains | $15.00 |
| Apr 1, 2025 | Cantor Fitzgerald | Ross Osborn | Overweight | Maintains | $9.00 |
| Mar 31, 2025 | D. Boral Capital | Jason Kolbert | Buy | Maintains | $15.00 |
| Feb 25, 2025 | D. Boral Capital | Jason Kolbert | Buy | Maintains | $23.00 |
| Jan 6, 2025 | D. Boral Capital | Jason Kolbert | Buy | Initiates | $23.00 |
| Dec 6, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Maintains | $12.00 |
| Nov 26, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Maintains | $11.00 |
| Sep 23, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Reiterates | $14.00 |
| May 31, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Reiterates | $17.00 |
| May 30, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Maintains | $17.00 |
| May 29, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Reiterates | $18.00 |
| Feb 15, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Reiterates | $18.00 |
| Jan 19, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Maintains | $18.00 |
| Nov 29, 2023 | Cantor Fitzgerald | Ross Osborn | Overweight | Maintains | $24.00 |
| Oct 3, 2023 | Cantor Fitzgerald | Ross Osborn | Overweight | Reiterates | $30.00 |
| Sep 26, 2023 | Cantor Fitzgerald | Steven Halper | Overweight | Reiterates | $30.00 |
| Sep 8, 2023 | Alliance Global Partners | Ben Haynor | Buy | Initiates | $14.50 |
| Aug 22, 2023 | Cantor Fitzgerald | Steven Halper | Overweight | Reiterates | $30.00 |
| Aug 18, 2023 | Cantor Fitzgerald | Steven Halper | Overweight | Reiterates | $30.00 |
| Jun 14, 2023 | Cantor Fitzgerald | Steven Halper | Overweight | Reiterates | $30.00 |
Nano-X Imaging Ltd. (NNOX) Competitors
The following stocks are similar to Nano-X based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nano-X Imaging Ltd. (NNOX) Financial Data
Nano-X Imaging Ltd. has a market capitalization of $334.11M with a P/E ratio of 0.0x. The company generates $11.28M in trailing twelve-month revenue with a -94.0% profit margin.
Revenue growth is +25.2% quarter-over-quarter, while maintaining an operating margin of -496.5% and return on equity of -27.8%.
Valuation Metrics
Market Cap
$334.11M
Enterprise Value
$264.53M
P/E Ratio
0.0x
PEG Ratio
-9.4x
Price/Sales
29.6x
Growth & Margins
Revenue Growth (YoY)
+25.2%
Gross Margin
-96.3%
Operating Margin
-496.5%
Net Margin
-94.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+21.9%
Current Ratio
5.6x
Debt/Equity
3.9x
ROE
-27.8%
ROA
-16.5%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Nano-X Imaging Ltd. (NNOX) Business Model
About Nano-X Imaging Ltd.
What They Do
Develops innovative medical imaging technologies.
Business Model
The company generates revenue by developing and commercializing advanced X-ray systems, such as the 'Nanox.ARC' and accompanying software platform 'Nanox.CLOUD'. These products aim to enhance diagnostic capabilities and accessibility, particularly in underserved markets, which can drive adoption and sales among healthcare providers.
Additional Information
Nano-X Imaging is positioned to address the challenges of traditional imaging solutions, including high costs and infrastructure complexity. Its focus on integrating artificial intelligence with imaging technologies may significantly improve early disease detection and contribute to global health initiatives, making it a notable player in the medical devices sector.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
165
CEO
Mr. Erez I. Meltzer
Country
Israel
IPO Year
N/A
Website
www.nanox.visionNano-X Imaging Ltd. (NNOX) Latest News & Analysis
Latest News
Quick Summary
Nanox Imaging Ltd (Nasdaq: NNOX) will report Q1 2025 financial results on May 22, 2025, before market open. A conference call will follow at 8:30 a.m. with CEO Erez Meltzer and CFO Ran Daniel.
Why It Matters
Nanox's upcoming financial results and conference call may influence investor sentiment and stock performance, providing insights into the company's growth and operational direction.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Why Nano-X Imaging Stock Soared Today
24 days ago
Quick Summary
Nano-X Imaging (NNOX) shares rose 14.2% in Thursday trading, as the company aims to disrupt the medical device market with a per X-ray delivery business model.
Why It Matters
Nano-X Imaging's stock surge indicates strong market interest in its innovative business model, potentially signaling future revenue growth and disruption in the medical devices sector.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Nanox Imaging Ltd (Nasdaq: NNOX) received FDA 510(k) clearance for its Nanox.ARC X system, allowing production of tomographic images for various medical uses, within 30 days of submission.
Why It Matters
FDA clearance for Nanox's imaging system accelerates market entry, potentially boosting revenue. Positive regulatory news can enhance investor confidence and drive stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Why Nanox Stock Slumped Today
1 month ago
Quick Summary
Nano-X Imaging (NNOX) saw a nearly 5% drop in stock price after its latest earnings release, leading to a sell-off among investors on Monday.
Why It Matters
Nano-X Imaging's nearly 5% drop post-earnings indicates negative market sentiment, which could signal declining confidence in its financial performance and future growth potential.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
Nano-X Imaging Ltd. (NASDAQ:NNOX) will hold its Q4 2024 earnings conference call on March 31, 2025, at 8:30 AM ET, featuring key executives and analysts from various firms.
Why It Matters
The earnings call indicates upcoming financial results for Nano-X Imaging, providing insights into performance and future guidance, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
The ADOPT study reveals that Nanox.AI improves fracture detection and contributes to healthcare cost savings, indicating potential benefits for investors in the healthcare technology sector.
Why It Matters
Nanox.AI's improved fracture detection may lead to increased market adoption and revenue growth, while potential healthcare cost savings could enhance overall profitability, attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About NNOX Stock
What is Nano-X Imaging Ltd.'s (NNOX) stock forecast for 2025?
Based on our analysis of 6 Wall Street analysts, Nano-X Imaging Ltd. (NNOX) has a median price target of $11.50. The highest price target is $15.00 and the lowest is $9.00.
Is NNOX stock a good investment in 2025?
According to current analyst ratings, NNOX has 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.24. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NNOX stock?
Wall Street analysts predict NNOX stock could reach $11.50 in the next 12 months. This represents a 119.5% increase from the current price of $5.24. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Nano-X Imaging Ltd.'s business model?
The company generates revenue by developing and commercializing advanced X-ray systems, such as the 'Nanox.ARC' and accompanying software platform 'Nanox.CLOUD'. These products aim to enhance diagnostic capabilities and accessibility, particularly in underserved markets, which can drive adoption and sales among healthcare providers.
What is the highest forecasted price for NNOX Nano-X Imaging Ltd.?
The highest price target for NNOX is $15.00 from Jason Kolbert at D. Boral Capital, which represents a 186.3% increase from the current price of $5.24.
What is the lowest forecasted price for NNOX Nano-X Imaging Ltd.?
The lowest price target for NNOX is $9.00 from Ross Osborn at Cantor Fitzgerald, which represents a 71.8% increase from the current price of $5.24.
What is the overall NNOX consensus from analysts for Nano-X Imaging Ltd.?
The overall analyst consensus for NNOX is bullish. Out of 6 Wall Street analysts, 4 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $11.50.
How accurate are NNOX stock price projections?
Stock price projections, including those for Nano-X Imaging Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2025 4:03 PM UTC